Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes
Jaret Malloy, Kate Gurney, Kevin Shan, Ping Yan, Steve ChenAmylin Pharmaceuticals LLC, San Diego, CABackground: Recent studies have demonstrated an increased incidence of pancreatitis in patients with type 2 diabetes compared with obese nondiabetic individuals. Serum lipase and pancreatic amylase co...
Guardado en:
Autores principales: | Malloy J, Gurney K, Shan K, Yan P, Chen S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb92757f130b475d9e488e8958ab1851 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
por: MacConell L, et al.
Publicado: (2015) -
Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials
por: Gurney K, et al.
Publicado: (2012) -
Current management strategies to target the increasing incidence of diabetes within Pakistan [Corrigendum]
por: Basit A, et al.
Publicado: (2019) -
Anthropometric cutoff values for detecting metabolic abnormalities in Jordanian adults
por: Yousef S Khader, et al.
Publicado: (2010) -
Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes
por: Montane J, et al.
Publicado: (2014)